Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LPCN stock hub

Lipocine Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LPCNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

19M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LPCN

In the news

Latest news · LPCN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-54.4

P25 -105.6P50 -46.5P75 -3.1

ROIC-35.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LPCN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001535955
Company name	Lipocine Inc.
Country	United States
Country code	US
Cusip	53630X104
Employees	14
Employees Change	-2%
Employees Change Percent	-12.5
Enterprise value	$-5.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US53630X2036
Last refreshed	2026-05-10
Market cap	$19M
Market cap category	Nano-Cap
Price	$2.37
Price currency	USD
Rev Per Employee	143,015x
Sector	Healthcare
Sic	2834
Symbol	LPCN
Website	https://www.lipocine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-60.12%
FCF yield	-52.83%
P/B ratio	0.78x
P/S ratio	9.5x
PS Forward	35.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$2M
Gross Profit Growth	-45.52%
Gross Profit Growth Q	27.2%
Gross Profit Growth3 Y	53.37%
Net Income	$-11.4M
Net Income Growth Years	0%
Pretax Margin	-571.1%
Profit Per Employee	$-816,752
ROA	-33.07
Roa5y	-16.96
ROCE	-53.13
ROE	-54.41
Roe5y	-28.24
ROIC	-35.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-34.02%
Cagr1y	-28.2%
Cagr3y	-16.9%
Cagr5y	-36.87%
EPS Growth Years	0
Revenue Growth	-45.52x
Revenue Growth Q	27.2x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	53.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.09
Assets	$25.4M
Cash	$24.7M
Current Assets	$25.2M
Current Liabilities	$2.5M
Equity	$22.8M
Liabilities	$2.5M
Long Term Assets	$113,232
Long Term Liabilities	$0
Net Cash	$24.7M
Net Cash By Market Cap	$130
Net Cash Growth	27.65%
Net Debt Equity	$-1.08
Tangible Book Value	$22.8M
Tangible Book Value Per Share	$3.05
WACC	7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.99
Net Working Capital	$-2M
Quick ratio	9.87
Working Capital	$22.7M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.67%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.44%
1Y total return	-28.18%
200-day SMA	4.8
3Y total return	-42.63%
50-day SMA	5.01
50-day SMA vs 200-day SMA	50over200
5Y total return	-89.97%
All Time High	340
All Time High Change	-99.3%
All Time High Date	2013-08-28
All Time Low	1.81
All Time Low Change	30.94%
All Time Low Date	2026-04-02
ATR	0.31
Beta	0.5
Beta1y	0.05
Beta2y	0.54
Ch YTD	-70.49
High	2.5
High52	12.37
High52 Date	2026-01-15
High52ch	-80.84%
Low	2.35
Low52	1.81
Low52 Date	2026-04-02
Low52ch	30.94%
Ma50ch	-52.73%
Premarket Change Percent	0.42
Premarket Price	$2.4
Premarket Volume	3,152
Price vs 200-day SMA	-50.6%
RSI	33.09
RSI Monthly	41.35
RSI Weekly	34.86
Sharpe ratio	0.59x
Sortino ratio	0.78
Total Return	-8.67%
Tr YTD	-70.49
Tr1m	18.5%
Tr1w	1.72%
Tr3m	-72.08%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Hold
Earnings EPS Estimate	$-0.49
Earnings Revenue Estimate	150,000x
Earnings Revenue Estimate Growth	59.81x
Operating Income	$-12.1M
Operating margin	-605.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,121,884%
Float Percent	88.74%
Shares Insiders	4.65%
Shares Institutions	17.07%
Shares Out	8,025,115
Shares Qo Q	19.61%
Shares Yo Y	8.67%
Short Float	2.16%
Short Ratio	0.18
Short Shares	1.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.3M
Average Volume	264,729.2x
Bv Per Share	3.05
Ch10y	-98.44
Ch1m	18.5
Ch1w	1.72
Ch1y	-28.18
Ch3m	-72.08
Ch3y	-42.63
Ch5y	-89.97
Ch6m	-6.69
Change	-0.84%
Change From Open	-1.66
Close	2.39
Days Gap	0.84
Depreciation Amortization	60,026
Dollar Volume	446,704.7
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-12.1M
EBITDA	$-12.1M
EPS	$-1.97
F Score	1
FCF	$-10M
FCF EV Yield	176x
FCF Per Share	$-1.25
Financing CF	14,840,594
Fiscal Year End	December
Founded	1,997
Investing CF	-3,130,981
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2023-05-12
Last Split Type	Reverse
Last10k Filing Date	2026-03-10
Ma150	5.4
Ma150ch	-56.11%
Ma20	2.39
Ma20ch	-0.71%
Net CF	1,661,012
Next Earnings Date	2026-08-04
Open	2.41
Optionable	No
Position In Range	13.33
Ppne	89,479
Pre Close	2.39
Price Date	2026-05-08
Ptbv Ratio	0.83
Relative Volume	0.71x
Revenue	2,002,210x
SBC By Revenue	11.83x
Share Based Comp	236,893
Tr6m	-6.69%
Us State	Utah
Volume	188,483

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LPCN pay a dividend?

Capital-return profile for this ticker.

Performance

LPCN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LPCN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.1%

Float: +88.7% of shares outstanding

Insider ownership

+4.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LPCN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.1

Neutral momentum band

Price vs 200-day MA

-50.6%

50/200-day relationship not available

Beta (5Y)

0.50

Less volatile than the market

Sharpe ratio

0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LPCN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LPCN stock rating?

Lipocine Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LPCN analysis?

The full report lives at /stocks/LPCN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LPCN?

The latest report frames LPCN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LPCN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.